Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

NNOX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

NNOX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Nano-X Imaging Ltd.(NNOX US)

$0.29-0.0310.24%Ext:$0.36+0.0725.79%(Market Closed · 01:00:08 UTC)
ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees

Nano-X Imaging Ltd.(NNOX US)

$0.29-0.0310.24%Ext:$0.36+0.0725.79%(Market Closed · 01:00:08 UTC)
ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees
Ask AI
Ask AI

Nano-X Imaging Ltd. — Company Profile

Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.

Sector
Industrials
Industry
Commercial Services & Supplies
Exchange
UQ
CEO
Erez I. Meltzer
Headquarters
Petah Tikva, IL
IPO Date
Aug 21, 2020
Employees
197
Website
www.nanox.vision

Key Metrics

Price
$0.64
Market Cap
$44.25M
Revenue (TTM)
$4.16M
Net Income (TTM)
$-55487000.00
EPS (TTM)
-0.79
P/E (TTM)
-0.59
P/B (TTM)
0.61
Dividend Yield
0.00%
ROE (TTM)
-76.57%
ROA (TTM)
-60.85%
Operating Margin
-13.35%
Beta

Nano-X Imaging Ltd. — Company Profile

Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.

Sector
Industrials
Industry
Commercial Services & Supplies
Exchange
UQ
CEO
Erez I. Meltzer
Headquarters
Petah Tikva, IL
IPO Date
Aug 21, 2020
Employees
197
Website
www.nanox.vision

Key Metrics

Price
$0.64
Market Cap
$44.25M
Revenue (TTM)
$4.16M
Net Income (TTM)
$-55487000.00
EPS (TTM)
-0.79
P/E (TTM)
-0.59
P/B (TTM)
0.61
Dividend Yield
0.00%
ROE (TTM)
-76.57%
ROA (TTM)
-60.85%
Operating Margin
-13.35%
Beta
1.10

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.

Website
www.nanox.vision
Location
Petah Tikva, IL
Phone972 02 5360360
Employees197
CEOErez I. Meltzer
Sector
Industrials
Industry
Commercial Services & Supplies
IPO DateAug 21, 2020

Latest Documents

News

  • Nanox to Report Third Quarter 2026 Financial Results on November 25, 202616 Nov
  • Nanox Announces Distribution Agreement with Medworks for Nanox.AI in Greece13 Nov
  • Nanox.AI Advances Commercial Collaboration with Dosy Health to Bring AI Cardiac Solution to Thailand10 Nov
  • Nanox Announces That Board Has Approved Cost Reduction and Operational Efficiency Measures9 Nov
  • USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows9 Nov
  • TCT 2026 Clinical Data Reveals 84% Reporting Gap in Aortic Valve Calcification, Highlighting the Potential of Nanox.AI's AVC Solution2 Nov
  • Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for Third Quarter Ended September 30, 202616 Oct
  • Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l.16 Oct
  • Nanox Selected as One of TIME's Best Inventions of 2026 for its Nanox.ARC X15 Oct
  • Nano-X Imaging Ltd. (NASDAQ:NNOX) Given Average Recommendation of “Moderate Buy” by Analysts21 Sep
  • Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica10 Sep
  • Nano-X Imaging Ltd. (NNOX) Q2 2026 Earnings Call Transcript9 Sep
  • Nano-X Imaging Q2 Earnings Call Highlights9 Sep
  • Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates9 Sep
  • Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England4 Sep
  • Nanox to Report Second Quarter 2026 Financial Results on September 9, 202625 Aug
  • Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom18 Aug

Key Stats

Trading

Px/Chg 1D$0.64 / -4.02%
Avg Volume1.79M
Beta1.10
Mkt Cap44.25M
FD Mkt Cap55.97M

Float

Shrs Out/Float69.60M / 63.98M
Short Float0.10%
Days to Cover1.12
Stock Repurchased$0.00

Current Valuation

EV20.95M
EV/EBITDA-0.43
EV/Sales1.61
P/B0.61
P/S3.40
FCF Yield-28.43%
ROE-76.57%
ROA-60.85%
Current Ratio2.84

Estimates

P/E-0.59
Est P/E0.00
Est EPS-0.14
Est PEG0.00

Valuation

Metric5Yr AvgMay '23Aug '24May '25Sep '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-4.81-8.87-6.71-5.74-1.94-0.80
Price / Sales41.06108.8241.2027.2317.4110.65
Price / Book Value1.824.312.091.620.460.61
Price / Free Cash Flow-8.69-18.46-8.49-7.80-5.18-3.52
ENTERPRISE VALUE METRICS
Enterprise Value315.9899.6360.1275.323.420.9
Enterprise Value / Sales35.40104.8736.3624.406.315.04
Enterprise Value / EBITDA-5.50-11.88-7.55-6.12-1.56-0.40
Enterprise Value / EBIT-4.58-10.32-6.04-4.85-1.31-0.38

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue77.8%1.38.69.911.313.0
Gross Income70.5%-1.5-6.9-6.6-10.6-12.8
EBITDA-4.6%-59.3-75.7-47.7-45.0-49.0
EBIT-35.1%-61.6-87.2-59.7-56.7-60.7
Net Income5%-61.8-105.2-60.8-53.5-75.0
EPS (Diluted)-2.4%-1.28-2.01-1.08-0.91-1.16
BALANCE SHEET
Cash & ST Inv-9.5%88.777.682.473.259.6
Total Assets-18.3%363.2253.9218.6210.0162.2
Total Liabilities-25%71.037.323.120.922.4
Total Shareholder Equity-16.8%292.1216.7195.5189.1139.7
CASH FLOW
Net Operating Cash Flow1.7%-38.1-43.4-44.8-36.6-40.8
Cap Ex-34.7%-23.2-7.2-3.3-2.8-4.2
Free Cash Flow-7.4%-61.2-50.6-48.1-39.4-45.0

Enterprise Value Bridge

Millions USD17 Nov '26
Price (As of 17 Nov '26)0.29
Basic Shares69.60
Market Cap20.2
Diluted Shares69.93
Fully Diluted Shares Outstanding69.93
Fully Diluted Market Cap20.3
+Consolidated Debt7.7
−In-the-Money Convertible Debt—
+Capital Leases4.8
+Operating Leases—
−Cash & Equivalents-31.0
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value-3.1

Related companies

Apple Inc.

AAPL US

Kla Corp

KLAC US

Medtronic Public Limited Company

MDT US

Stryker Corp

SYK US

3M Company

MMM US

Northrop Grumman Corp /DE/

NOC US

Coherent Corp.

COHR US

Boston Scientific Corp

BSX US

Lenovo Group Ltd

LNVGY US

Garmin Ltd

GRMN US

HOYA Corporation

HOCPY US

Becton Dickinson & Co

0R19 LN

1.10

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.

Website
www.nanox.vision
Location
Petah Tikva, IL
Phone972 02 5360360
Employees197
CEOErez I. Meltzer
Sector
Industrials
Industry
Commercial Services & Supplies
IPO DateAug 21, 2020

Latest Documents

News

  • Nanox to Report Third Quarter 2026 Financial Results on November 25, 202616 Nov
  • Nanox Announces Distribution Agreement with Medworks for Nanox.AI in Greece13 Nov
  • Nanox.AI Advances Commercial Collaboration with Dosy Health to Bring AI Cardiac Solution to Thailand10 Nov
  • Nanox Announces That Board Has Approved Cost Reduction and Operational Efficiency Measures9 Nov
  • USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows9 Nov
  • TCT 2026 Clinical Data Reveals 84% Reporting Gap in Aortic Valve Calcification, Highlighting the Potential of Nanox.AI's AVC Solution2 Nov
  • Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for Third Quarter Ended September 30, 202616 Oct
  • Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l.16 Oct
  • Nanox Selected as One of TIME's Best Inventions of 2026 for its Nanox.ARC X15 Oct
  • Nano-X Imaging Ltd. (NASDAQ:NNOX) Given Average Recommendation of “Moderate Buy” by Analysts21 Sep
  • Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica10 Sep
  • Nano-X Imaging Ltd. (NNOX) Q2 2026 Earnings Call Transcript9 Sep
  • Nano-X Imaging Q2 Earnings Call Highlights9 Sep
  • Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates9 Sep
  • Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England4 Sep
  • Nanox to Report Second Quarter 2026 Financial Results on September 9, 202625 Aug
  • Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom18 Aug

Key Stats

Trading

Px/Chg 1D$0.64 / -4.02%
Avg Volume1.79M
Beta1.10
Mkt Cap44.25M
FD Mkt Cap55.97M

Float

Shrs Out/Float69.60M / 63.98M
Short Float0.10%
Days to Cover1.12
Stock Repurchased$0.00

Current Valuation

EV20.95M
EV/EBITDA-0.43
EV/Sales1.61
P/B0.61
P/S3.40
FCF Yield-28.43%
ROE-76.57%
ROA-60.85%
Current Ratio2.84

Estimates

P/E-0.59
Est P/E0.00
Est EPS-0.14
Est PEG0.00

Valuation

Metric5Yr AvgMay '23Aug '24May '25Sep '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-4.81-8.87-6.71-5.74-1.94-0.80
Price / Sales41.06108.8241.2027.2317.4110.65
Price / Book Value1.824.312.091.620.460.61
Price / Free Cash Flow-8.69-18.46-8.49-7.80-5.18-3.52
ENTERPRISE VALUE METRICS
Enterprise Value315.9899.6360.1275.323.420.9
Enterprise Value / Sales35.40104.8736.3624.406.315.04
Enterprise Value / EBITDA-5.50-11.88-7.55-6.12-1.56-0.40
Enterprise Value / EBIT-4.58-10.32-6.04-4.85-1.31-0.38

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue77.8%1.38.69.911.313.0
Gross Income70.5%-1.5-6.9-6.6-10.6-12.8
EBITDA-4.6%-59.3-75.7-47.7-45.0-49.0
EBIT-35.1%-61.6-87.2-59.7-56.7-60.7
Net Income5%-61.8-105.2-60.8-53.5-75.0
EPS (Diluted)-2.4%-1.28-2.01-1.08-0.91-1.16
BALANCE SHEET
Cash & ST Inv-9.5%88.777.682.473.259.6
Total Assets-18.3%363.2253.9218.6210.0162.2
Total Liabilities-25%71.037.323.120.922.4
Total Shareholder Equity-16.8%292.1216.7195.5189.1139.7
CASH FLOW
Net Operating Cash Flow1.7%-38.1-43.4-44.8-36.6-40.8
Cap Ex-34.7%-23.2-7.2-3.3-2.8-4.2
Free Cash Flow-7.4%-61.2-50.6-48.1-39.4-45.0

Enterprise Value Bridge

Millions USD17 Nov '26
Price (As of 17 Nov '26)0.29
Basic Shares69.60
Market Cap20.2
Diluted Shares69.93
Fully Diluted Shares Outstanding69.93
Fully Diluted Market Cap20.3
+Consolidated Debt7.7
−In-the-Money Convertible Debt—
+Capital Leases4.8
+Operating Leases—
−Cash & Equivalents-31.0
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value-3.1

Related companies

Apple Inc.

AAPL US

Kla Corp

KLAC US

Medtronic Public Limited Company

MDT US

Stryker Corp

SYK US

3M Company

MMM US

Northrop Grumman Corp /DE/

NOC US

Coherent Corp.

COHR US

Boston Scientific Corp

BSX US

Lenovo Group Ltd

LNVGY US

Garmin Ltd

GRMN US

HOYA Corporation

HOCPY US

Becton Dickinson & Co

0R19 LN